Ameritas Investment Partners, Inc. Bio Xcel Therapeutics, Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	BUY	$20.12 - $35.09 $5,432 - $9,474	270 Added 25.0%	1,350 $27,000
Q1 2021 May 14, 2021	BUY	$39.04 - $64.6 $5,660 - $9,367	145 Added 15.51%	1,080 $47,000
Q2 2020 Aug 05, 2020	BUY	$17.62 - $58.71 $7,118 - $23,718	404 Added 76.08%	935 $50,000
Q2 2019 Aug 14, 2019	BUY	$8.99 - $11.79 $4,773 - $6,260	531 New	531 $6,000

3.11M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $8.41M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.